Protein traffic from the secretory pathway to the endosomal system in pancreatic beta-cells.
Constitutive-like secretion involves vesicular trafficking corresponding kinetically and biochemically with a post-trans-Golgi network (TGN) origin. In pancreatic beta-cells, the budding of AP-1/clathrin-coated vesicles, a portion of which is derived from immature secretory granules, has been hypothesized to initiate constitutive-like trafficking. However, approximately 30 min after release of a 20 degrees C intracellular transport block in pancreatic beta-cells (to synchronize protein egress from the TGN), addition of brefeldin A (BFA) (which inhibits AP-1 recruitment) was reported not to block subsequent constitutive-like secretion. To further explore post-TGN trafficking in pancreatic beta-cell lines, we have followed the fate of pulse-labeled procathepsin B (ProB, a lysosomal proenyzme) after postpulse wortmannin treatment or the BFA treatment described above. We find that continuous wortmannin treatment allows ProB to reach immature secretory granules but inhibits its egress from maturing granules. Remarkably, BFA treatment causes augmented unstimulated secretion of newly synthesized ProB that is not paralleled by insulin. This effect requires a delay of 25-35 min after release from the 20 degrees C block. Further, when ProB delivery to endosomes is inhibited, its BFA-augmented secretion is eliminated. We hypothesize that the constitutive-like pathway involves an endosomal intermediate.
Turner
M D
MD
Diabetes Center, Division of Endocrinology and the Department of Developmental and Molecular Biology, Albert Einstein College of Medicine, Bronx, New York 10461, USA.
Arvan
P
P
D000730:Androstadienes / Q000494:pharmacology; D000818:Animals; D001692:Biological Transport; D020126:Brefeldin A / Q000494:pharmacology; D002401:Cathepsin B / Q000378:metabolism; D011992:Endosomes / Q000378:metabolism*; D004792:Enzyme Precursors / Q000378:metabolism; D007328:Insulin / Q000378:metabolism; D007515:Islets of Langerhans / Q000187:drug effects / Q000378:metabolism* / Q000648:ultrastructure; D008247:Lysosomes / Q000201:enzymology; D011506:Proteins / Q000378:metabolism*; D051381:Rats; D000077191:Wortmannin
D000730:Androstadienes; D004792:Enzyme Precursors; D007328:Insulin; D011506:Proteins; D020126:Brefeldin A; C057832:procathepsin B; D002401:Cathepsin B; D000077191:Wortmannin